Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Manhattan Scientifics enters into a non-binding LOI with Edward R. Flynn

Manhattan Scientifics announced today that it has entered into a non-binding letter of intent (LOI) with Edward R. Flynn, Ph.D. and his company, Senior Scientific, LLC, to acquire all the manufacturing and marketing rights, together with all commercial rights associated with Dr. Flynn’s patents and IP in the emerging field of nanomedicine.

21 Oct 2009

Suntron's Phoenix, Arizona facility receives ISO 13485:2003 certification

Suntron Corporation, a leader in the area of integrated Electronics Manufacturing Solutions (EMS) and Commercial Off The Shelf (COTS) technology with six (6) North American production facilities, announced today they have received their International Organization for Standardization (ISO) 13485:2003 certification for their Southwest Operations in Phoenix, AZ.

21 Oct 2009

Cambrex wins the CPhI Innovation Award for its Continuous-Flow Microwave-Assisted Organic Synthesis technology

Cambrex Corporation announced today that it won the Silver Innovation Award at the 2009 CPhI Event for its Continuous-Flow Microwave-Assisted Organic Synthesis (CFMAOS) technology. The award was accepted by Dr. Jayne E. Muir (Market Research & New Technologies - Europe), who presented the technology to a panel of judges at this important pharmaceutical ingredients exhibition in Madrid, Spain on October 13, 2009.

21 Oct 2009

CHA urges California Nurses Association to promote vaccinations to all health care workers

The California Hospital Association (CHA) is engaged with hospitals and state and local public health officials in a voluntary statewide effort to ensure that all hospital workers -- including registered nurses -- are vaccinated against the H1N1 flu virus.

21 Oct 2009

Simcere and OSI Pharmaceuticals to market KDR/Kit inhibitor OSI-930 in China

Simcere Pharmaceutical Group ("Simcere" or the "Company"), a leading pharmaceutical company specializing in development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement with OSI Pharmaceuticals, Inc., to develop, manufacture, and market its KDR/Kit inhibitor OSI-930 in China.

21 Oct 2009

TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program

TechnoVax, Inc., a biotechnology developer of novel vaccines was awarded a three-year $2.9 million SBIR phase II grant from the National Institutes of Health to further the development of its VLP-based, vaccine program.

20 Oct 2009

Biogen Idec announces total revenues of $1.12 billion for third quarter 2009

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today reported its third quarter 2009 results.

20 Oct 2009

GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda

GlaxoSmithKline Inc. (GSK) As part of its broad commitment to improving access to medicines and its ongoing support for Canada's Access to Medicines Regime (CAMR), GlaxoSmithKline confirms it will not object - through CAMR - to allow Canadian company (Apotex) to continue manufacturing their drug for the treatment of HIV/AIDS in Rwanda.

20 Oct 2009

A.P. Pharma to raise funds through placement

A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.

20 Oct 2009

PhRMA calls for appropriate incentives for continued biotechnology innovation

Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding appropriate incentives for continued biotechnology innovation:

20 Oct 2009

Novavax, Avimex and GE Healthcare initiate clinical study of H1N1 VLP influenza vaccine

Novavax, Inc. (Nasdaq: NVAX) announced today that it has initiated a two-stage clinical study of its virus-like-particle (VLP) H1N1 influenza vaccine in Mexico in collaboration with Avimex Laboratories (Avimex) and GE Healthcare.

20 Oct 2009

Shire Canada supports initiative for further access to antiretroviral medicine for Rwanda

Shire Canada Inc., a division of Shire plc, announced today its voluntary cooperation to enable further royalty-free access to HIV/AIDS medicines for Rwanda as part of ongoing collaborative efforts to improve health and save lives in the developing world.

20 Oct 2009

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

20 Oct 2009

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.

20 Oct 2009

Bio-Bridge Science receives business license for Bio-Bridge JRS Biosciences (Beijing)

Bio-Bridge Science, Inc., a biotechnology company engaged in the commercial development of vaccines and vaccine-related products announced today that the Company received a business license from the Beijing Administration for Industry and Commerce of the People’s Republic of China (“PRC”) indicating approval of the formation of Bio-Bridge JRS Biosciences (Beijing) Co., Ltd. (“Bio-Bridge JRS”).

20 Oct 2009

Article evaluating StemEx therapy for leukemia and lymphoma to be published

Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx", as a therapy for blood cancers such as leukemia and lymphoma.

19 Oct 2009

Circle Medical Devices and Texcel Medical to provide medical product design and manufacturing solutions

Circle Medical Devices of Los Gatos, Calif., and Texcel Medical of Springfield, Mass., have merged to create CIRTEC Medical Systems, a leading provider of comprehensive medical product design and manufacturing solutions.

19 Oct 2009

URL Pharma's Colcrys approved by FDA for prevention of gout flares

URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.

19 Oct 2009

New series of single output power supplies from ICC

International Components Corporation (ICC), an established global leader in designing and manufacturing portable rechargeable systems, today launched a new series of high-efficiency AC-DC open-frame, single output power supplies marketed under the Elpac Power Systems(TM) brand name.

19 Oct 2009

Talecris Biotherapeutics' PROLASTIN-C receives FDA approval

Talecris Biotherapeutics (Nasdaq: TLCR) today received approval from the U.S. Food and Drug Administration for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more concentrated version of PROLASTIN® produced using advances in manufacturing technology.

19 Oct 2009

Manufacturing News and Research

Further Reading

Manhattan Scientifics enters into a non-binding LOI with Edward R. Flynn

Suntron's Phoenix, Arizona facility receives ISO 13485:2003 certification

Cambrex wins the CPhI Innovation Award for its Continuous-Flow Microwave-Assisted Organic Synthesis technology

CHA urges California Nurses Association to promote vaccinations to all health care workers

Simcere and OSI Pharmaceuticals to market KDR/Kit inhibitor OSI-930 in China

TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program

Biogen Idec announces total revenues of $1.12 billion for third quarter 2009

GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda

A.P. Pharma to raise funds through placement

PhRMA calls for appropriate incentives for continued biotechnology innovation

Novavax, Avimex and GE Healthcare initiate clinical study of H1N1 VLP influenza vaccine

Shire Canada supports initiative for further access to antiretroviral medicine for Rwanda

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

Bio-Bridge Science receives business license for Bio-Bridge JRS Biosciences (Beijing)

Article evaluating StemEx therapy for leukemia and lymphoma to be published

Circle Medical Devices and Texcel Medical to provide medical product design and manufacturing solutions

URL Pharma's Colcrys approved by FDA for prevention of gout flares

New series of single output power supplies from ICC

Talecris Biotherapeutics' PROLASTIN-C receives FDA approval

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News